Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
Kirk Brown(John Hunter Hospital), Vasant Jadhav(Alnylam Pharmaceuticals (United States))
Cited by 239
Related Papers
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
|Molecular Therapy — Nucleic Acids|2013|37
Expanding the Reach of RNAi Therapeutics with Next Generation Lipophilic siRNA Conjugates
|Research Square|2021|3